Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathologic myopia
Editorial Group: Cochrane Eyes and Vision Group
Published Online: 15 JUN 2014
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Zhu Y, Zhang T, Xu G, Peng L. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathologic myopia (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No.: CD011160. DOI: 10.1002/14651858.CD011160.
- Publication Status: New
- Published Online: 15 JUN 2014
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation (CNV), compared to other treatments, sham treatment or no treatment, in patients with pathologic myopia.